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Introduction:Although recognized with increasing frequency, the pathogenesis of venous aneurysms (VA) remains poorly
understood.We evaluated 8 patients with 10 VA for the presence, localization and activity of metalloproteinases (MMPs).
Methods: Tissue specimens from VA (n8), normal saphenous vein (NSV n7) and varicose veins (VV n7 were
compared by histology and immunohistochemistry (IHC). Histologic sections were stained with H&E, Movats
pentachrome and toluidine blue, and IHC specimens with antibodies to CD68, MMP2, MMP9, and MMP13. Protein
expression and enzyme activity were determined by Western immunoblotting and zymography.
Results: Three of 4 patients with popliteal VA presented with edema and leg pain and the remaining patient with deep
venous thrombosis (DVT) and pulmonary embolism (PE). The 5 popliteal VA were treated by; excision and reanasto-
mosis (n2) lateral venorrhaphy (n2) and spiral saphenous vein graft (n1). The 3 patients with 4 upper extremity VA
had discomfort over a compressible mass. Two of the VA were excised and the remaining patients aneurysm ruptured
spontaneously. The mesenteric VA, an incidental finding at laparotomy was excised. Thrombus was present in 2 popliteal,
1 upper extremity and in the mesenteric aneurysm.Histologically, VA and VVwere characterized by fragmentation of the
elastic lamellae, loss of smooth muscle cells (SMCs) and attenuation of the venous wall when compared to NSV. Varicose
veins and VA also demonstrated increased expression of MMP-2, MMP-9 andMMP-13 in endothelial cells (ECs), SMCs
and adventitial microvessels compared to NSV. Both pro-MMP-2 and pro-MMP-9 were detected by zymography in
VA,VV and NSV but only MMP-2 activity was demonstrable.
Conclusions: The structural changes in the venous wall in addition to the increased expression of MMP-2, MMP-9 and
MMP-13 in VA compared to NSV and VV suggests a possible causal role for these MMPs in their pathogenesis. ( J Vasc
Surg 2008;48:1278-85.)Venous aneurysms (VAs) are uncommon focal saccular
or fusiform dilations that communicate with the accompa-
nying normal vein by a single channel. The incidence of
VAs is unknown. VAs can occur at any age and in either sex
with equal frequency. There is usually no history of ante-
cedent trauma, association with an arteriovenous commu-
nication or pseudoaneurysm, and the lesion should not be
contained within a segment of varicose vein (VV).1,2
VAs are classified according to their location and have
been reported in association with the major veins of the
neck, thorax, and abdomen as well as the deep and super-
ficial veins of the upper or lower extremities.3-17 The nat-
ural history and clinical significance of VAs is related to
their location and size. Neck and upper extremity VAs are
usually asymptomatic and are most frequently treated be-
cause of their size and cosmetic appearance. Thoracic and
abdominal VAs are usually asymptomatic and are detected
incidentally on computed tomography (CT) or magnetic
resonance (MRI) imaging scans.6,10,11 In contrast to tho-
racic VAs, abdominal VAs are more liable to complications
such as gastrointestinal hemorrhage and thromboembo-
lism and are treated when discovered.6 Popliteal VAs, the
most common of the extremity deep VAs, are usually found
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1278during the evaluation of patients with thromboembolic
disease or chronic venous insufficiency.1,5,16,18
Although VAs and their potential for complications are
well recognized, their pathogenesis remains poorly under-
stood. In this study, we analyzed venous tissue from eight
patients with 10 VAs to determine the possible role of
matrix metalloproteinases (MMPs) in the pathogenesis of
these lesions.
MATERIALS AND METHODS
Tissue samples. Patient demographic data were ob-
tained from review of their medical records and imaging
studies. Venous tissue from seven patients with VVs, eight
with VAs (5 popliteal, 2 of 4 extremity, 1 mesenteric), and
seven with normal saphenous veins (NSVs), used as refer-
ence tissue, was analyzed. Each specimen was divided into
three segments: one was snap frozen in liquid nitrogen for
protein analysis, another was placed in RNALater (Applied
Biosystems/Ambion, Austin, Tex) for RNA extraction,
and the remaining portion was preserved in Streck Tissue
Fixative (STF; Streck Laboratories, Omaha, Neb) or in 10%
phosphate-buffered formalin for histology and immunohis-
tochemistry (IHC). Samples were collected in accordance
with the requirements of the Institutional Review Board at
the University of Texas Medical Branch, Galveston, Texas.
Histologic analysis and IHC. Paraffin-embedded ve-
nous tissue (5-m) sections from eight VAs were compared
by histology and IHC with seven NSVs and seven VVs.
Specimens were stained with hematoxylin and eosin andMo-
vat’s pentachrome, and selected specimens with toluidine
blue. For IHC, sections were stained with specific antibodies
to factor V111 antigen, CD-68, andMMP-2, -9, and -13. In
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Slideswere deparaffinized, rehydrated, and processed for IHC
on an automated Optimax immunostainer (BioGenex, San
Ramon, Calif). Antigen retrieval was performedwith BioGenex
Antigen Retrieval Citra Plus (pH 6.0) for 10 minutes at
100°C.
The slides were rinsed in distilled water, treated for 5
minutes with 0.3% hydrogen peroxide in 100%methanol to
remove endogenous peroxidase activity, and then predi-
gested in 0.0025% protease in phosphate-buffered saline
(pH 7.6) for 30 minutes at room temperature. The slides
were counterstained with hematoxylin. Endothelial cells
were identified with staining for factor VIII antigen and
macrophages with CD-68 antibodies (Dako Corp, Carpen-
teria, Calif). Sections were also stained with antibodies to
MMP-2, -9, and -13. Human placenta and pancreatic
adenocarcinoma were used as positive controls. The pri-
mary antibodies were omitted for negative control speci-
mens. Two to three separate sections from each specimen
were examined by two blinded observers.
Western blot analysis. Antibodies for MMP-2,
MMP-9, tissue inhibitor of metalloproteinase-2 (TIMP-2;
Oncogene Research Products, Cambridge, Mass), and
-actin (Sigma, St. Louis, Mo) were used for Western
immunoblotting. Briefly, tissue for NSVs, VVs, and two
VAs were homogenized on ice for 1 minute in radioim-
munoprecipitation assay (RIPA) lysis buffer (50 nM
Tris-hydrogen chloride, pH 7.5; 150mM sodium chloride,
1% [wt/vol] sodium deoxycholate, 0.1% sodium dodecyl
sulfate, 100 mM sodium orthovanadate , 1% [vol/vol]
Triton X-100 [Fisher Chemicals, Pittsburgh, Pa]), and
complete Mini-EDTA (ethylenediaminetetraacetic acid)-
free protease inhibitors (Roche Molecular Biochemicals,
Dorval, Quebec, Canada). Tissue homogenates were cen-
trifuged (4°C at 8000 g) for 20 minutes, and supernatants
were collected. Polyacrylamide gels were prepared (stack-
ing gel, 4%; separating gel, 10%), and the proteins (50
g/well) were separated by polyacrylamide gel electro-
phoresis and then transferred electrophoretically to a 0.45-
m-pore polyvinylidene difluoride membrane.
The blots were washed with Tris-buffered saline with
Tween-20 (TBS-T; 150 mM sodium chloride; 20 mM
Tris-hydrogen chloride, and 0.1% Tween-20 ; pH 7.5)
and incubated overnight with blocking solution (5% skim
milk powder in TBS-T). The blots were incubated with the
appropriate primary antibodies at 1:1000 dilution for 1
hour, rinsed three times for 5 minutes each with TBS-T,
and incubated with secondary rabbit antiserum conjugated
with horseradish peroxidase (1:2000 dilution in blocking
solution; 1% milk) for 1 hour.
After incubation with the secondary antibody, the blots
were washed three times, 5minutes each, and the antibody-
antigen complex was detected using the ECL Plus detec-
tion system (Amersham Biosciences, Piscataway, NJ). The
membranes were then exposed to X-OMAT blue film
(Kodak Scientific Imaging Products, Rochester, NY), and
the intensities of immunoreactive bands were measured by
scanning (6200C scanner, Hewlett Packard Canada Ltd,Mississauga, Ontario, Canada). The images were analyzed
on a desktop computer using Kodak 1D Image Analysis
.3.6 software (Eastman Kodak Co, Rochester, NY). The
mean pixel density for each band was analyzed to obtain
relative OD units for specific proteins. To standardize for
sample loading, the relative OD units for each band were
standardized to the relative OD units of the total -actin.
RNA isolation. Venous tissue was preserved in
RNALater and total RNA extracted with RNAzol using the
Ultraspec RNA Isolation System according to the manu-
facturer’s protocol (Biotex, Houston, Tex). The quality of
total RNA was controlled by agarose gel electrophoresis as
demonstrated by the presence of intact ribosomal RNA
(28S and 18S).
One-step real-time reverse transcription-polymerase
chain reaction procedure, primers, and probes. We
used Applied Biosystems assays-on-demand 20 assay mix
of primers and TaqMan MGB probes (FAM dye-labeled)
for our target gene and predeveloped 18S rRNA (VIC-dye
labeled probe) TaqMan assay reagent (P/N 4319413E) for
endogenous control.
Relative quantitation of gene expression. Separate
tubes (singleplex) one-step reverse transcription-polymerase
chain reaction (RT-PCR) was performed with 40 ng RNA
for both target genes and endogenous control. The reagent
we used was TaqMan one-step RT-PCR master mix re-
agent kit (P/N 4309169). The cycling parameters for
one-step RT-PCR was: reverse transcription 48°C for 30
minutes, AmpliTaq activation 95°C for 10 minutes, dena-
turation 95°C for 15 seconds, and annealing/extension
60°C for 1 minute (repeat 40 times) on the ABI7000
(Applied Biosystems). Duplicate CT values were analyzed
in Excel software (Microsoft Corp, Redmond, Wash) using
the comparative CT (CT) method as described by the
manufacturer (Applied Biosystems). The amount of target
(2CT) was obtained by normalizing to an endogenous
reference (18s) and relative to a calibrator (one of the
experimental samples).
Zymography. Protein was mixed (1:1) with Novex
tris-glycerine-sodium dodecylsulfate buffer (Invitrogen,
Carlsbad, Calif) and incubated at room temperature for 10
minutes. The samples were loaded into a Novex 10% Zy-
mogram gelatin gel (Invitrogen) and electrophoresis was
initiated. The gel was stained with Coomassie blue R-250
for 30 minutes and then destained with Coomassie R250
destaining solution.
RESULTS
Patient demographics are summarized in the Table.
VAs were detected in seven men and one woman. Popliteal
VAs (n 5) were the most common aneurysms seen in this
study. The diagnosis was made by ultrasonography, MRI,
or phlebography (Figs 1 and 2). In two patients, there was
sufficient redundancy to allow excision of the VA and
end–end anastomosis. The patient with bilateral popliteal
VAs, who presented with DVT and pulmonary embolism,
had excision of both VAs and repair by lateral venorrhaphy.
lcohol
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repair is shown in Fig 3. The remaining patient had excision
of the VA, and the defect was reconstituted with a spiral
saphenous vein graft. The graft subsequently occluded
despite the patient being fully anticoagulated with warfarin
sodium. The remaining four popliteal VA repairs remained
patent by duplex ultrasound scanning between 9 and 84
months after their surgery. The patient with the occluded
vein graft repair has minimal pedal edema controlled with
support hose.
Two of four extremity VAs were excised without recur-
rence in the follow-up period (Fig 4). The most recent
patient seen with an upper extremity VA had a similar lesion
excised 40 years previously from the left antecubital fossa.
The VA on his right forearm ruptured spontaneously while
awaiting excision and is presently partially thrombosed.
Table. Patient demographics
Age Sex Site Medical history
56 F Popliteal Right lower extrem
DVT, pulmonary
hypertension
58 M Popliteal None
46 M Bilateral Pulmonary embolis
Popliteal Same
71 M Popliteal CAD, ETOH abuse
26 M Forearm None
32 M Hand None
82 M Bilateral forearm Hypertension
65 M Mesenteric Cirrhosis
CAD, Coronary artery disease; DVT, deep vein thrombosis; ETOH, ethyl a
Fig 1. Color flow duplex ultrasound image of a typical
(B) transverse views.The mesenteric VA was an incidental finding at laparotomyand excised. The patient died during the postoperative
period from unrelated causes.
Thrombus was present in two popliteal VAs, one upper
extremity VA, and the mesenteric VA. Histologic examina-
tion demonstrated significant structural differences be-
tween the three types of specimens. The intima of NSVs
was characterized by a single layer of endothelial cells (ECs)
with occasional foci of intimal thickening and a well-
formed medial layer consisting of elastic lamellae, collagen,
smooth muscle cell (SMC) bundles, and proteoglycans.
The adventitial layer was composed of muscle fibers, colla-
gen, fibroblasts, SMCs, and vaso vasorum. The endothelial
layer of the diseased vein segments was discontinuous in-
terspersed with areas of intimal thickening. The walls of
both VVs and VAs were thinner than NSVs due to frag-
mentation and attenuation of the elastic fibers, loss of
Symptoms Size, cm Intervention
Right leg pain 2  2 Excision,
reanastomosis
Left knee pain 4  3 Spiral vein graft
Dyspnea syncope 4  4 Bilateral
Excision
Same 4  2 Venorrhaphy
Left leg pain 1.7  2.5 Excision,
reanastomosis
Right arm pain 2  2 Ligation/excision
Right hand pain 2.5  2.5 Ligation/excision
Mass 2  2 Spontaneous
rupture
Incidental 6  4 Ligation/excision
.
teal venous aneurysm in (A) longitudinal andity
mpopliSMCs, and an increase in collagen content.
) an
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metric and involved part or the circumference of the wall in
different venous segments.Occasional CD68-positively stain-
Fig 2. Phlebography showing lobulated (A
Fig 3. Operative photograph shows the (A) venous an
completion of the repair.ing inflammatory cells were detected by IHC in the speci-mens examined. Mast cells were demonstrated in all three
specimens, with a greater number of these cells in VVs.
Medial calcification was noted in the wall of the mesenteric
d saccular (B) popliteal venous aneurysms.
(VA) exposed, (B) thrombus in the lumen, and (C)eurysmaneurysm. MMP-2, -9, and -13 were expressed in ECs,
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in NSVs or VVs (Fig 5). MMP-2 and MMP-9 were de-
tected in all three types by Western immunoblotting, but
the differences between the types of tissue were variable and
not statistically different. TIMPS-2 was also detected in all
three types of tissue (Fig 6), with one specimen in each
group showing greater expression of the inhibitor than the
others. Zymography showed expression of both pro-
MMP-2 and pro-MMP-9. However, only MMP-2 activity
could be demonstrated (Fig 7). RT-PCR of NSVs, VVs,
and VAs, as well as DNA sequencing of one VA, showed no
evidence of fibrillin.
DISCUSSION
The degradation and remodeling of the extracellular
matrix byMMPs has been implicated in the pathogenesis of
abdominal aortic aneurysms (AAAs) and VVs. Because of
the association of MMPs with AAAs (MMP-2, MMP-9)
and VVs (MMPs-1, -2, -3, -9, -13), we postulated that
MMPs may also play a role in the pathogenesis of VAs.19-23
In this study, we analyzed and compared tissue samples
from patients with VAs, VVs, and NSVs to determine if
there were any differences in the expression and localization
of MMP-2, -9, and -13. We selected MMP-13 for this
analysis because of its wide spread specificity for fibrillar
collagens type I, II, III, XI, laminin, fibronectin, tenascin,
and gelatin and its ability to activate pro-MMP-9.24
Histologically, several morphologic differences were
evident between VAs, VVs, and NSVs. Focal areas of endo-
thelial denudation, fragmentation, and attenuation of the
elastic lamellae, loss of SMCs, andmedial fibrosis in areas of
thrombus adherence were characteristic findings in VA and
to a lesser extent in VV specimens. The morphologic
changes in both VVs and VAs may only involve part of the
circumference of the venous wall. The asymmetric distribu-
tion of the disease process explains the feasibility of using
lateral venorrhaphy to repair VAs. Fragmentation of elastic
tissue is a characteristic feature of both arterial and venous
aneurysms. Dobrin and Mrkvicka25 have shown in experi-
Fig 4. A venous aneurysm of the hand is shown.mental studies that the dissolution of elastic tissue in arterialsegments leads to dilatation of the vessel wall. Whether
fragmentation of the elastic tissue lamellae is a precursor to
dilatation in the venous wall has not been determined.
The expression of MMP-2, -9, and -13 was localized to
SMCs, ECS, and microvascular ECs lining adventitial mi-
crovessels in VAs by IHC. These MMPs were only infre-
quently detected in VVs or NSVs. MMP expression in
patients with AAAs has been correlated with the intensity of
the inflammatory cell infiltrate.19 An unexpected finding in
the specimens we examined was the infrequent occurrence
of inflammatory cells. Only occasional positively staining
CD-68 cells were detected in the media and adventitia of
the three types of venous specimen. Mast cells, another
source of proteases, were also observed in these two regions
of the vessel wall, but most often in VV specimens.
Although SMCs and ECS are known to express MMPs
and other proteases, the significance of MMP expression by
the cells and the factors inducing their expression remain
uncertain. Recent human and experimental studies suggest
that the expression of MMPs by SMCs and ECs may
influence the relaxation/constriction properties of the ve-
nous wall and contribute to the development of VVs. Also,
the loss of endothelial integrity may expose the compo-
nents of the vessel wall to degradation by MMPs.21,26 The
quantity of MMPs produced by SMCs and ECs, compared
with that produced by macrophages—the predominant
source of MMPs—appears to be insufficient to account for
the morphologic changes in the venous wall. The infre-
quent detection of positively staining CD68 cells in our
study contrasts with the observations of Sayer and Smith,27
who found macrophages and mast cells widely distributed
throughout all the layers of the venous wall. Possible expla-
nations for the differences between these two studies may
relate to regional differences in the intensity of the inflam-
matory response and MMP expression, specimen sampling
bias, or the stage of the disease. The absence of regional
differences in mast cell tryptase or chymasemessenger RNA
or protein expression suggests that these cells only play a
limited role in the matrix changes seen in VVs.23
The expression of MMP-2 and MMP-9 by Western
immunoblotting was quite variable and did not correlate
with the IHC findings. Similarly TIMP-2 was detected in
all three types of tissue, but the levels of expression did not
correlate with that of MMP-2. The lack of correlation
between the IHC findings and Western immunoblotting
may relate to the asymmetric distribution of the vessel wall
changes, the levels of protein expression, or differences in
the epitopes used. Although both pro-MMP-2 and pro-
MMP-9 were present, only MMP-2 activity was demon-
strable by zymography.
Increased tissue expression and plasma levels of MMPs
1, -2, -3, -9, and -13 has been demonstrated in patients
with VVs, and MMPs-2, -9, and -13 in tissue of patients
with VAs in the present study. The relevance of these
findings to the pathogenesis of VAs is presently unknown.
Whether the presence of these proteases is merely a mani-
festation of ongoing inflammation or contributes to the
mato
ated i
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tic of VVs and VAs remains to be determined.23,25,27
Because fibrillin-rich microfibrils are essential to the for-
mation and integrity of elastin and fragmentation of the elastic
lamellae as a prominent feature of VVs and VAs, we evaluated
all three specimen types with RT-PCR but were unable to
demonstrate any fibrillin in the tissues examined.28
An interesting observation is the absence of reports
in the literature of the concurrent detection of arterial
and venous aneurysms in the same individual, which
Fig 5. Histology and immunohistochemistry comparin
venous aneurysm (original magnification 200) demon
venous aneurysm. The expression of matrix metalloprote
compared with normal vein and varicose vein. H&E, He
Fig 6. Western immunoblot demonstrating variable exp
tissue inhibitor of metalloproteinase (TIMP)-2 in varic
aneurysm (VA). One specimen in each group demonstrsuggests that the local and systemic factors mediatinganeurysmal degeneration in arterial and venous tissue
may be different.
This study has several limitations. Evaluation of human
VAs represents end-stage disease and may not reflect the
factors that initiate or contribute to the pathogenesis of these
lesions. The amount of tissue available for analysis remains a
problem. Because of their rarity, it is unlikely that prospective
studies of VAs will be undertaken. A multicenter registry and
prospective collection of tissue samples may provide some of
the answers. Ultimately, what is lacking is the availability of
resentative sections of normal vein, varicose vein, and
ng attenuation of the venous wall in varicose vein and
(MMP) -2, -9, and -13 is increased in venous aneurysms
xylin and eosin.
on of matrix metalloproteinase (MMP) -2, MMP-9, and
ein (VV), normal saphenous vein (NSV), and venous
ncreased expression of TIMP-2.g rep
strati
inaseressi
ose vanimal models of venous disease.
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In this preliminary study we have demonstrated in-
creased expression of MMP-2, -9, and -13 in VAs com-
pared with NSVs and VVs. This observation in conjunction
with the morphologic changes in the extracellular matrix of
venous aneurysmal lesions suggests a possible causal role
for MMPs in their pathogenesis.
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